X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (21) 21
carbonic anhydrase ix (19) 19
humans (18) 18
hypoxia (17) 17
oncology (15) 15
antigens, neoplasm - genetics (10) 10
cancer (10) 10
expression (10) 10
antigens, neoplasm - metabolism (9) 9
carbonic anhydrases - genetics (8) 8
tumors (8) 8
carbonic anhydrases - metabolism (7) 7
cell line, tumor (7) 7
medical prognosis (7) 7
mice (7) 7
proteins (7) 7
animals (6) 6
articles (6) 6
female (6) 6
hypoxia-inducible factor 1, alpha subunit - metabolism (6) 6
male (6) 6
metastasis (6) 6
transcriptional regulation (6) 6
endothelial growth-factor (5) 5
gene expression (5) 5
health aspects (5) 5
carbonic-anhydrase-ix (4) 4
cell hypoxia (4) 4
cell proliferation (4) 4
chemotherapy (4) 4
enzymes (4) 4
identification (4) 4
metabolism (4) 4
middle aged (4) 4
patients (4) 4
promoter regions, genetic (4) 4
biochemistry & molecular biology (3) 3
blotting, western (3) 3
breast-cancer (3) 3
cancer therapies (3) 3
carbonic anhydrase ix - metabolism (3) 3
carcinoma (3) 3
care and treatment (3) 3
cell growth (3) 3
cell hypoxia - drug effects (3) 3
cell movement (3) 3
dexamethasone (3) 3
growth (3) 3
migration (3) 3
mutation (3) 3
neoplasm invasiveness (3) 3
pathology (3) 3
physiological aspects (3) 3
research (3) 3
rodents (3) 3
signal transduction - drug effects (3) 3
acidosis (2) 2
activation (2) 2
antibodies, monoclonal - immunology (2) 2
antigens, neoplasm - analysis (2) 2
antigens, neoplasm - immunology (2) 2
bacterial infections - complications (2) 2
bacterial infections - diagnosis (2) 2
basic oxygen furnace dust and sludge (2) 2
binding sites (2) 2
braf (2) 2
ca-ix (2) 2
cancer stem-cells (2) 2
carbon dioxide (2) 2
carbonic anhydrase ix - genetics (2) 2
carbonic anhydrases - analysis (2) 2
cell biology (2) 2
cell movement - drug effects (2) 2
cell proliferation - drug effects (2) 2
cells (2) 2
child, preschool (2) 2
dna-binding proteins - genetics (2) 2
domain (2) 2
down-regulation (2) 2
drug therapy (2) 2
gene (2) 2
gene expression regulation, neoplastic - drug effects (2) 2
gene-expression (2) 2
genes, reporter (2) 2
genetics & heredity (2) 2
genotype & phenotype (2) 2
hela cells (2) 2
hydrometallurgy (2) 2
hypoxia-inducible factor (2) 2
hypoxia-inducible factor 1, alpha subunit - genetics (2) 2
hypoxia-inducible factor-1-alpha (2) 2
hypoxia-inducible factor-1α (2) 2
immunohistochemistry (2) 2
indoles - pharmacology (2) 2
inducible factor-i (2) 2
intracellular ph (2) 2
invasive breast-carcinoma (2) 2
kinases (2) 2
leaching (2) 2
linked-immunosorbent-assay (2) 2
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Neoplasia, ISSN 1476-5586, 2013, Volume 15, Issue 4, pp. 435 - IN22
Journal Article
International Journal of Oncology, ISSN 1019-6439, 10/2016, Volume 49, Issue 4, pp. 1277 - 1288
Journal Article
Potravinarstvo Slovak Journal of Food Sciences, ISSN 1337-0960, 04/2019, Volume 13, Issue 1, pp. 244 - 250
Mastitis is still one of the major causes of economic losses in dairy sector. The routine application of bacteriologic examination of milk samples is often... 
S. uberis | mastitis | lipid peroxidation | cows | lactation | coagulase negative staphylococci
Journal Article
International Journal of Oncology, ISSN 1019-6439, 7/2015, Volume 47, Issue 1, pp. 51 - 60
Journal Article
Cancer Research, ISSN 0008-5472, 10/2014, Volume 74, Issue 19 Supplement, pp. 508 - 508
Journal Article
International Journal of Oncology, ISSN 1019-6439, 7/2015, Volume 47, Issue 1, pp. 81 - 90
Chondroitin sulfate proteoglycan 4 (CSPG4), a highly immunogenic melanoma tumor antigen, is a potential target for antibody-based immunotherapy. The mechanism... 
hypoxia-inducible factor 1α | vemurafenib | hypoxia | melanoma | chondroitin sulfate proteoglycan 4 | Vemurafenib | Hypoxia | Hypoxia-inducible factor la | Chondroitin sulfate proteoglycan 4 | Melanoma | CARBONIC-ANHYDRASE-IX | TUMOR HYPOXIA | MONOCLONAL-ANTIBODY | BRAF | CANCER | METASTATIC MELANOMA | ONCOLOGY | CUTANEOUS MELANOMA | ADAPTIVE RESISTANCE | GROWTH | EXPRESSION | hypoxia-inducible factor 1 alpha | Carbonic Anhydrases - genetics | Humans | Indoles - administration & dosage | Carbonic Anhydrases - metabolism | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Melanoma - genetics | Antigens, Neoplasm - metabolism | Indoles - pharmacology | Gene Expression Regulation, Neoplastic - drug effects | Carbonic Anhydrase IX | Melanoma - metabolism | Antigens, Neoplasm - genetics | Cell Hypoxia - drug effects | Hypoxia-Inducible Factor 1, alpha Subunit - genetics | Neoplasm Invasiveness | Chondroitin Sulfate Proteoglycans - antagonists & inhibitors | Sulfonamides - pharmacology | Antibodies - pharmacology | Xenograft Model Antitumor Assays | Antibodies - administration & dosage | Cell Movement - drug effects | Animals | Membrane Proteins - antagonists & inhibitors | Signal Transduction - drug effects | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Melanoma - therapy | Sulfonamides - administration & dosage | Pharmacology, Experimental | Proteoglycans | Drug interactions | Oncology, Experimental | Antibodies | Research | Chondroitin | Viral antibodies | Dosage and administration | Drug therapy | Health aspects | Cancer | Immunoglobulins | Cell growth | Medical prognosis | Chondroitin sulfate | Metastasis | Skin cancer
Journal Article